Vedanta Biosciences IPO

Vedanta Biosciences, founded in 2017, is a clinical-stage company that has developed immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays that seek to enable physicians to access live bacteria drugs that are designed to treat autoimmune and inflammatory diseases easily. Vedanta Biosciences is headquartered in Cambridge, Massachusetts.

Register for Details

For more details on financing and valuation for Vedanta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Vedanta Biosciences

Forge green plus iconForge green minus icon

What is Vedanta Biosciences's IPO price?

The IPO price for Vedanta Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Vedanta Biosciences?

Vedanta Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Vedanta Biosciences shares pre-IPO?

If you own Vedanta Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Vedanta Biosciences a publicly traded company?

Vedanta Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Vedanta Biosciences's funding to date?

Vedanta Biosciences has raised $211.6MM to date.
Forge green plus iconForge green minus icon

When was Vedanta Biosciences founded?

Vedanta Biosciences was founded in 2010.

Who are Vedanta Biosciences's major investors?

Bristol Myers Squibb
Bill & Melinda Gates Foundation
Rock Springs Capital
Johnson & Johnson Innovation
Magnetar Capital
Reimagined Ventures
Skyviews Life Science
SV Investment
Shumway Capital
PureTech Health
Fosun Health Capital

Vedanta Biosciences Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/21/2021 Series D $68.41MM raised $XXX.XX $XXX.XX
1/12/2021 Series C-2 $41.57MM raised $XXX.XX $XXX.XX
5/13/2019 Series C $45.39MM raised $XXX.XX $XXX.XX
12/21/2018 Series B $52.23MM raised $XXX.XX $XXX.XX
11/3/2017 Series A-1 $4MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.